📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark. (2020)

First Author: Ali MS

Attributed to: Lifecourse Determinants of Bone and Joint Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11657-020-00746-z

PubMed Identifier: 32483674

Publication URI: http://europepmc.org/abstract/MED/32483674

Type: Journal Article/Review

Volume: 15

Parent Publication: Archives of osteoporosis

Issue: 1